INTRODUCTION
Bony defects in the jaw occur for various reasons. They are caused by infection, tumors or cysts. To maintain teeth or to provide sufficient bone height for later implantation or prosthesis supply, the filling of bone defect is necessary (1) .
Grafting materials include autografts, allografts, xenografts and synthetic bone substitutes. However, the majority of grafting procedures are autografts. i.e. the graft is taken from the same patient. The graft can be harvested either intraorally; from the mandibular symphysis, retromolar region or maxillary tuberosity or extraorally; from the femur, tibia, ribs or iliac crest of the pelvis (2, 3) .
Nanocrystalline hydroxyapatite bone graft has been introduced for augmentation procedures in intrabony defects. Its Advantages are osteoconductivity and bioresorbablity (4) . When it is used as a bone graft substitute, rapid healing of critical size defects was observed in animal experiments and in human applications (4) . It binds to bone and stimulates bone healing by stimulation of osteoblastic activity (5) .
Nanobone® is a nanocrystalline hydroxyapatite embedded in a porous silica gel matrix. Unlike conventional HA forms that are usually sintered at temperatures ranging from 700°C up to 1200°C, Nanobone® is produced at a temperature < 200°C. The lower processing temperature has a profound effect on the material's porosity and surface area (6) .
The biocompatibility of titanium (Ti) has been proved in recent years. Titanium particles can stimulate the activation of complement system and platelets and can increase the level of platelet-derived growth factor. This factor has been shown to promote bone growth (7) . These properties of titanium are incorporated in porous titanium granules (PTG), which contain 700-1000 micrometers diameter granules, and its porous nature makes the bone infiltration through the particles possible (8) (9) (10) (11) (12) (13) .
Therefore, due to the scarce histological data on both PTG and Nanobone® this study was designed to compare histologically and histomorphometrically the osseous defect regeneration and bone volume value after applying PTG and Nanobone®.
MATERIALS AND METHODS
This study was conducted on 10 healthy adult mongrel dogs, about 18-24 months old, and with an average weight 10 to 15 kg. The animals were kept under the same nutritional and environmental conditions at the Physiology Department, Faculty of Medicine, Alexandria University. The dogs were divided equally into two groups (right side and left side);
Group I: A surgical defect was created in the right premolar area of the body of the mandible and was grafted with PTG (Natix™).
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Abstract:
Background: Bone grafting is a common technique in Oral and Maxillofacial surgery to replace missing bone. Grafting materials include autografts, allografts, xenografts and synthetic bone substitutes. Two synthetic bone materials are currently available; porous titanium granules and nanocrystalline hydroxyapatite.
Objectives: This study compared the use of Porous titanium granules (PTG) versus Nanobone® in healing of mandibular defects in dogs and this was estimated by histological and histomorphometric analysis.
Materials and Methods:
The study was conducted on 10 healthy experimental dogs. An osseous defect of 10mm depth and 10mm width was created in the premolar area of both right and left sides of the mandible. The right side defects were grafted with PTG while the left side defects were grafted with Nanobone®. Histological and histomorphometrical evaluation was carried out to monitor bone healing and quantify the bone volume with both PTG and Nanobone® at 3, 6 and 12 weeks intervals post-operatively.
Results:
The mean bone volume value with PTG was 773.4 ± 499.4 on the 3rd week, then increased on the 6th week to be 10125.3 ± 19287.3 and 2676.0 ± 1388.2 on the 12th week. The mean bone volume value with Nanobone® was 525.5 ± 332.1 on the 3rd week, then on the 6th week it became 287.4 ± 322.5. There was a statistically significant increase on the 12th to be 1976.8 ± 1568.1. . There was a statistically significant difference regarding the mean bone volume value between the two groups. Conclusion: Both PTG and Nanobone® have osteoconductive properties and are effective in healing bone defects, but the histomorphometric analysis quantified the bone volume with both PTG and Nanobone® and revealed that the maximum amount of the total regenerated bone was seen in the PTG group; bone was formed within its porosities Key Words: Porous Titanium Granules, Nanobone®, bone defects, bone volume, histomorphometric analysis. Group II: A surgical defect was created in the left premolar area of the body of the mandible and was grafted with Nanobone®.
Natix™ PTG (Tigran technologies AB: Medeon science park, S-205 12 Malano, Sweden) is a bone graft material made of pure titanium and available in vials. The titanium granules are between 0.7 mm and 1.0 mm in size, porous, irregular in shape, grey in color and non-resorbable. These irregularities enable the granules to interlock with bone thus enabling primary and long term stability through osteoconduction and osseointegration. Nanobone® (Nanograft: Pharma k dental Gmbh, Germany) consists of nanocrystalline HA embedded in a silica gel matrix. It has two forms; fine (0.6mm x 2mm) and rough (1mm x 2mm). All NanoBone® technology products are produced in a sol-gel process at temperatures below 200°C. The low temperatures means that the material is not sintered and its surface is therefore highly porous with pores ranging from nanometers to micrometers in size. The autologous proteins from the blood enter the nanopores and cover the entire inner surface.
All dogs were healthy as documented by a veterinarian report. All dogs were kept on the same balanced diet consisting of milk, broth and meat throughout the whole period of the study. Each animal received a single dose of antibiotics intravenously in the form of ampicillin 25 mg/kg body weight (Epico pharmaceutical co., 10th of Ramadan City, Cairo, Egypt) just before the operation. All operating procedures were performed under general anesthesia and strict sterile conditions in an animal theatre. Each animal was generally anaesthetized via intravenous injection of thiopentone sodium 5% (Egyptian international pharmaceutical industries company (E.I.P.co), the dose of which was calculated on the basis of 30 mg/kg body weight.
With the dogs under general anesthesia, a 5 cm gingival incision was performed on the buccal side in the premolar region on both sides of the dogs mandible and the mucoperiosteal flap was elevated, an Osseous defect of 10 mm depth and 10 mm width was created on both sides of the dogs mandible by the aid of a trephine bur on electric motor under copious saline irrigation ( fig.1 ). Group I: The right side of the body of the mandible was packed with PTG ( fig.2a ). Group II: The left side of the body of the mandible was packed with Nanobone® ( fig.2b ) 3/0 chromic cat gut was used to suture the flap.
Post-operatively, the animals were transferred to a clean cage to be kept under observation to assess the presence or absence of any infection, wound dehiscence or graft rejection, they were kept on soft diet consisting of bread, milk and broth during the first four weeks postoperatively, the dogs received intra-muscular injection in the form of (25-50mg/kg/dog of ampicillin) every 24 hours for 5 days post-operatively, the dogs received the same course of medication; anti-inflammatory and analgesic in the form of diclofenac potassium 25mg/day (Cataflam, Novartis pharma, cairo, Egypt) twice daily for 3 days. The animals were inspected clinically on the first few post-operative days and then weekly till the end of follow up period for the presence or absence of infection or any arising complications, also the general condition and healing of the surgical sites were inspected. The animals were sacrificed by an intravenous overdose of thiopentone sodium (three at the 3th week, three at the 6th week and four at the 12thweek). The mandibles were extirpated and hemisected through the symphysis. The specimens were then prepared for histological examination. After the slides had been stained by H&E stains, the histomorphometric analysis was performed.
The histomorphometric analysis is a quantitative analysis that helps histological assessment of bone phenotypes and allows comparison between groups even when the difference is not obvious. In this analysis, from each specimen obtained from both groups (I and II), five slides of the prepared H & E stained histological section were used. The slides were examined in an optical microscope (Aristoplan-Leitz®, Leica, Wetzlar, Hesse, Germany) at 100x magnification power, through a camera (Axio Cam MRc5®, Zeiss, Santo Amaro, SP, Brazil) connected to a computer. Using Leica Qwin 500 image analyzer computer software, the images were converted into digital files, standardizing the height, width and number of pixels per inch. The amount of bone formed with each group at 3, 6 and 12 weeks intervals was quantified in pixels. The mean of these values was assigned to each slide, and the value was used for statistical analysis.
The 
RESULTS

Macroscopic results
All animals tolerated the surgical procedure without complications, and they started to eat on the first postoperative day and exhibited a normal pattern of activity.
Healing was uneventful without any signs of infection or wound dehiscence. All blocks obtained from both group I and group II at 3, 6 and 12 weeks were prepared for microscopic and histomorphometric evaluation.
Microscopic results: Hematoxylin and Eosin stain
On the third postoperative week Group I (PTG group) Complete filling of the defect areas by dense collagen fibers with high vascularity surrounding the PTG with fibroblasts in between and old bone bordering the defect areas. No inflammatory reaction was detected. The mean bone volume value with PTG was 773.4 ± 499.4 mm3 on the 3rd week (Table 1, Fig. 3a) . Group II (Nanobone® group) Nanobone® filling the defect area with granulation tissue in between except for some areas of resorption of the graft material, as the inorganic components of Nanobone® were removed by decalcification process so it appeared as empty spaces. There is a few amount of fibrovascular tissue and old bone found at the periphery of the defect. No inflammatory cells were detected. The mean bone volume value with Nanobone® was 525.5 ± 332.1 mm3 on the 3rd week. (Table 1 , Fig. 3b )
On the sixth postoperative week Group I (PTG group)
The defect areas showed deposition of newly calcified bone spicules over the PTG surrounding irregular areas with remnants of homogenous PTG, osteoid ground substance of bone and slight fibers in between. The mean bone volume value with PTG was 10125.3 ± 19287.3 mm3 on the 6th week. (Table 2 , Fig. 4a )
Group II (Nanobone® group)
Although, Nanobone® still occupying parts of the defect areas, newly formed bony specules were seen occupying the resorbed graft areas. Nanobone® was separated from the old bone surface with some granulation tissue within the space. The active osteoblasts were observed rimming the new bone and connected to old bone. The mean bone volume value with Nanobone® was 287.4 ± 322.5 mm3 on the 6th week. (Table 2 , Fig .4b ) 
The defect areas were filled with newly formed bone spicules replacing areas of resorption of the graft material and connected to the old bone. There were areas of unresorbed Nanobone® still well demarcated from the newly formed bone and surrounded by fibrous tissue. The mean bone volume value with Nanobone® was 1976.8 ± 1568.1 mm3 on the 12th week. (Table 3 , Fig. 5b ) The mean bone volume value on the 3rd postoperative week showed no statistically significant difference when comparing PTG with Nanobone® in osseous defects regeneration (p = 0.393) ( Table 1) . While, the mean bone volume value on the 6th postoperative week showed a statistically significant difference when comparing PTG with Nanobone® in osseous defects regeneration (p = 0.004) ( Table 2) . Also, the mean bone volume value showed statistically significant difference on the12th postoperative week when comparing PTG with Nanobone® in osseous defects regeneration (p = 0.001) ( Table 3, fig.6 ). 
DISCUSSION
Reconstruction of maxillofacial continuity defects has always been a challenge for scientists and surgeons over the years. The main goal of the reconstruction of the maxillofacial region is to restore facial form, function, full rehabilitation of occlusion and articulation (14) . The present study was conducted to compare the effect of PTG and Nanobone® on bone healing of surgically created osseous defects in dogs. The dogs were divided equally into two groups; Alexandria Dental Journal. (2015) Vol.XX Pages:126-132 Group I: A surgical defect was created in the right side of the body of the mandible and was grafted with PTG. Group II: A surgical defect was created in the left side of the body of the mandible and was grafted with Nanobone®.
In this study, the experimental animals of choice were the Dogs due to several advantages including: being less expensive to maintain, cost effective to feed and they show patterns of bone accretion and peak bone mass profiles similar to those of human as well as true skeletal maturity (15) .
The present study revealed that PTG can be considered as an appropriate bone substitute material, and it can promote bone regeneration in bone defects due to its osteoconductive properties, these results agreed with Wohlfahrt et al in 2010 (16) who stated that significantly more bone was formed in PTG grafted defects compared to those left empty. The new bone grew both through the porosities of the granules and onto the implant surfaces.
PTG belongs to a class of material that may be preferable for filling cavities because it serves as a nonresorbable scaffold that promotes a three-dimensional matrix, which can stabilize and maintain the shape of the filled area. This agreed with Marei in 2010 (17) where PTG were packed around the implant in the coronal gap between the fixture and socket wall; PTG showed good stabilization of the implant and preferable osseointegration between bone and the implant surface without being resorbed.
The histomorphometric analysis in the present study revealed that the bone volume value in the osseous defects filled with PTG was higher than those occupied with Nanobone® but no statistically significant difference could be detected between the two groups. This agreed with Wälivaara and Abrahamsson in 2013 (18) where no statistically significant difference could be detected between autogenous bone or one of the bone graft substitutes, when they were used to fill osseous defects in dogs following apicectomy of mandibular premolars. This non -significant difference might be explained by sample size limitation.
The present study proved that PTG can be used in small defects without membrane. This disagreed with Ruiz RF et al. in 2014 (19) who found that the PTG particles must be covered by a membrane, especially when grafting larger defects, to control particle dislocation, promote clot stabilization and separate the PTG graft from undesired soft tissue cells.
Macroscopically, no signs of inflammation and complete healing of the surgical sites was observed in all dogs of both groups. These findings agree with those of Gholami in 2010 (20) who reported the application of PTG does not interfere with the initial healing of the surgical wound. Bone marrow around PTG was fatty vascular but in some locations where grafted material (BIO-OSS and BIO-GEN) were used , the bone marrow was fibrovascular which provides evidence that the bone formation remodeling process in the samples containing PTG was developing correctly.
There were no signs of infection, abnormal reaction, wound dehiscence or extrusion of the material in any of the dogs. This disagreed with GabAllah in 2014 (21) where gingival inflammation, apical migration of attachment epithelium and destruction of the periodontuim were detected. The signs of complete periodontium regeneration were not clearly seen when Nanobone® was tested in healing of periodontal defects in dogs in comparison with autogenous grafts and control groups.
In two studies performed by Gotz et al (22) in 2010 and Harms et al in 2012 (23) , they reported a high osteoconductivity of Nanobone®. The presence of silicate ions appears to promote the process of bone formation and remodeling at the bone-Hydroxyapatite interface. In contrast to what was observed with other HA-based bone substitute materials, the rapid osseointegration of Nanobone® seemed to prevent its complete degradation. The Nanobone® particles were completely and firmly embedded within newly formed bone without a detectable fibrous interface and with no indication of an adverse host reaction to the material. This agreed with the present study that showed varying amounts of newly formed bone found through the specimens. Well-mineralized regenerated bone with lamellar parallel-fibred structure and Haversian systems surrounded the residual NanoBone® particles. These results also were in accordance with Canullo L (24) in 2009 who concluded that NanoBone® showed good histological outcomes for augmenting maxillary sinus floor with critical bone volume. There was evidence of new bone formed at (3, 6 and 12) weeks in defects filled with NanoBone®. The area under the graft gradually filled with new bone adjacent to peripheral defective area with bundles of connective tissue fibers extending to surround the NanoBone® were observed. The bone formation became apparent with increasing time of implantation. This result was in accordance with Alaa, Jaber, Kadhim and Al-Soudani (25) in 2012 where the amount of new bone formed in NanoBone® filled defects was much more than that formed in controls when it was used in healing of experimentally induced frontal bone defects in rabbits.
The present study revealed complete healing of the defects in all dogs with new bone formation without the need to use a membrane. This result was in agreement with EL Dibany and Shoukry (26) in 2014 where the combined use of Nanobone® and PRF for bone regeneration following the enucleation of large mandibular odontogenic cysts induced accelerated bone healing and improved the quality and quantity of regenerated bone also without using a membrane.
Histologically, the results of the present study were: Group I; the defect areas showed signs of complete fusion and healing of PTG with formation of bone trabeculae and immature Haversian system. Complete filling of the defect area with thick, new well calcified bone and lines of demarcation with old bone, numerous old osteons and osteocytes. Woven bone is a weak structure and does not have well-organized tissues (27) and it is the first bone tissue that is formed in the bone regeneration process (28) . Regarding Group II, bone formation was seen in direct contact with surface of NanoBone® granules, also there was
